Posiphen and phenserine are a new class of small compounds that reduce the development of Aβ in the brain while blocking the APP 5′-UTR IRE RNA-directed translation of APP in astrocytoma and neuroblastoma cell lines and in rats [141]. The gene discussed is APP; the disease is astrocytoma (excluding glioblastoma).